If you need more lookups,
subscriptions start at $34 USD/month.
Amy Raskopf Location
Darien, CT, US
Amy Raskopf Work
Chief Business Development Officer @ (May 2024 - Present)
SVP, Investor Relations @ (August 2022 - May 2024)
VP, Investor Relations @ (January 2021 - August 2022)
Investor Relations @ (February 2018 - January 2021)
President @ Raskopf Communications, LLC (November 2005 - January 2021)
Director, Corporate Communications @ Juniper Pharmaceuticals, Inc. (September 2015 - March 2017)
Senior Communications Strategist @ (March 2011 - August 2015)
Manager, Investor Relations @ Columbia Laboratories, Inc. (June 2004 - September 2005)
Senior Associate @ In-Site Communications, Inc. (April 2002 - February 2004)
Senior Account Executive @ (January 2000 - January 2002)
Senior Account Executive @ (January 2000 - January 2002)
Amy Raskopf Education
Southern Methodist University
MFA (Costume, Lighting and Set Design)
1994-1997
Smith College
AB (Theater)
1989-1993
Amy Raskopf Skills
Business Strategy
Corporate Communications
Investor Relations
Message Development
Crisis Communications
Communication Training
Media Relations
Press Releases
Speech Writing
Strategic Communications
Publicity
Marketing Communications
Communications Planning
Internal Communications
Messaging
Thought Leadership
Crisis Management
Corporate Social Responsibility
Public Relations
Strategy
Competitive Analysis
Start-ups
Marketing
Start Ups
Amy Raskopf Summary
Amy Raskopf, based in Darien, CT, US, is currently a Chief Business Development Officer at Evofem Biosciences. Amy Raskopf brings experience from previous roles at Evofem Biosciences and Raskopf Communications, LLC. Amy Raskopf holds a 1994 - 1997 MFA in Costume, Lighting and Set Design @ Southern Methodist University. With a robust skill set that includes Business Strategy, Corporate Communications, Investor Relations, Message Development, Crisis Communications and more. Amy Raskopf has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Amy Raskopf?
Find contact details for 700 million professionals.